keepcalm
2022-01-05

$Pfizer(PFE)$ Pfizer will be a surefire winner in 2022 as a company regardless of what happens with the COVID-19 pandemic. It already has major supply deals lined up for its COVID-19 vaccine and pill that will generate billions of dollars in revenue. Pfizer's lineup also includes multiple other growth drivers like blood thinner Eliquis and rare heart disease drug Vyndaqel/Vyndamax.

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法